nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP2C9—Donepezil—Alzheimer's disease	0.0938	0.373	CbGbCtD
Triazolam—CYP3A4—Rivastigmine—Alzheimer's disease	0.0682	0.271	CbGbCtD
Triazolam—CYP3A4—Donepezil—Alzheimer's disease	0.0545	0.217	CbGbCtD
Triazolam—CYP3A4—Galantamine—Alzheimer's disease	0.0351	0.14	CbGbCtD
Triazolam—Incontinence—Galantamine—Alzheimer's disease	0.0112	0.0305	CcSEcCtD
Triazolam—GABRQ—forebrain—Alzheimer's disease	0.00465	0.0274	CbGeAlD
Triazolam—Aggression—Galantamine—Alzheimer's disease	0.00444	0.0121	CcSEcCtD
Triazolam—Delusion—Donepezil—Alzheimer's disease	0.00427	0.0117	CcSEcCtD
Triazolam—GABRQ—telencephalon—Alzheimer's disease	0.00427	0.0252	CbGeAlD
Triazolam—Depersonalisation—Memantine—Alzheimer's disease	0.00392	0.0107	CcSEcCtD
Triazolam—Delusion—Memantine—Alzheimer's disease	0.00388	0.0106	CcSEcCtD
Triazolam—GABRR1—forebrain—Alzheimer's disease	0.00388	0.0228	CbGeAlD
Triazolam—Depersonalisation—Rivastigmine—Alzheimer's disease	0.00383	0.0105	CcSEcCtD
Triazolam—TSPO—blood vessel—Alzheimer's disease	0.00381	0.0224	CbGeAlD
Triazolam—Delusion—Rivastigmine—Alzheimer's disease	0.0038	0.0104	CcSEcCtD
Triazolam—Mania—Memantine—Alzheimer's disease	0.00378	0.0103	CcSEcCtD
Triazolam—Nightmare—Galantamine—Alzheimer's disease	0.00377	0.0103	CcSEcCtD
Triazolam—Eye irritation—Donepezil—Alzheimer's disease	0.00354	0.00967	CcSEcCtD
Triazolam—Aggression—Donepezil—Alzheimer's disease	0.00344	0.0094	CcSEcCtD
Triazolam—GABRD—forebrain—Alzheimer's disease	0.00337	0.0199	CbGeAlD
Triazolam—GABRG1—forebrain—Alzheimer's disease	0.00324	0.0191	CbGeAlD
Triazolam—Dysarthria—Donepezil—Alzheimer's disease	0.0032	0.00873	CcSEcCtD
Triazolam—Hearing impaired—Donepezil—Alzheimer's disease	0.00318	0.00868	CcSEcCtD
Triazolam—GABRA5—forebrain—Alzheimer's disease	0.00313	0.0184	CbGeAlD
Triazolam—Aggression—Memantine—Alzheimer's disease	0.00313	0.00854	CcSEcCtD
Triazolam—GABRD—telencephalon—Alzheimer's disease	0.0031	0.0183	CbGeAlD
Triazolam—Aggression—Rivastigmine—Alzheimer's disease	0.00306	0.00835	CcSEcCtD
Triazolam—Thinking abnormal—Memantine—Alzheimer's disease	0.003	0.00819	CcSEcCtD
Triazolam—GABRG1—telencephalon—Alzheimer's disease	0.00298	0.0176	CbGeAlD
Triazolam—GABRA6—telencephalon—Alzheimer's disease	0.00297	0.0175	CbGeAlD
Triazolam—Glossitis—Rivastigmine—Alzheimer's disease	0.00292	0.00796	CcSEcCtD
Triazolam—GABRB1—telencephalon—Alzheimer's disease	0.00289	0.017	CbGeAlD
Triazolam—Hearing impaired—Memantine—Alzheimer's disease	0.00289	0.00788	CcSEcCtD
Triazolam—GABRA5—telencephalon—Alzheimer's disease	0.00288	0.0169	CbGeAlD
Triazolam—Dysarthria—Rivastigmine—Alzheimer's disease	0.00284	0.00776	CcSEcCtD
Triazolam—GABRA4—forebrain—Alzheimer's disease	0.00284	0.0167	CbGeAlD
Triazolam—Coordination abnormal—Memantine—Alzheimer's disease	0.0028	0.00764	CcSEcCtD
Triazolam—Coordination abnormal—Rivastigmine—Alzheimer's disease	0.00274	0.00747	CcSEcCtD
Triazolam—Urinary retention—Galantamine—Alzheimer's disease	0.00269	0.00736	CcSEcCtD
Triazolam—Ataxia—Galantamine—Alzheimer's disease	0.00266	0.00728	CcSEcCtD
Triazolam—Nightmare—Memantine—Alzheimer's disease	0.00265	0.00724	CcSEcCtD
Triazolam—Depressed level of consciousness—Memantine—Alzheimer's disease	0.00265	0.00724	CcSEcCtD
Triazolam—GABRA4—telencephalon—Alzheimer's disease	0.00261	0.0154	CbGeAlD
Triazolam—Euphoric mood—Donepezil—Alzheimer's disease	0.0026	0.0071	CcSEcCtD
Triazolam—Nightmare—Rivastigmine—Alzheimer's disease	0.00259	0.00709	CcSEcCtD
Triazolam—GABRR3—nervous system—Alzheimer's disease	0.00252	0.0149	CbGeAlD
Triazolam—GABRQ—nervous system—Alzheimer's disease	0.00252	0.0149	CbGeAlD
Triazolam—Muscular weakness—Galantamine—Alzheimer's disease	0.0025	0.00682	CcSEcCtD
Triazolam—GABRQ—central nervous system—Alzheimer's disease	0.00243	0.0143	CbGeAlD
Triazolam—Mental disability—Memantine—Alzheimer's disease	0.00238	0.00651	CcSEcCtD
Triazolam—GABRB2—forebrain—Alzheimer's disease	0.00237	0.014	CbGeAlD
Triazolam—GABRG2—forebrain—Alzheimer's disease	0.00237	0.014	CbGeAlD
Triazolam—Mental disability—Rivastigmine—Alzheimer's disease	0.00233	0.00637	CcSEcCtD
Triazolam—Sleep disorder—Memantine—Alzheimer's disease	0.0023	0.00629	CcSEcCtD
Triazolam—TSPO—embryo—Alzheimer's disease	0.00227	0.0134	CbGeAlD
Triazolam—Sleep disorder—Rivastigmine—Alzheimer's disease	0.00225	0.00615	CcSEcCtD
Triazolam—Disorientation—Memantine—Alzheimer's disease	0.00223	0.00609	CcSEcCtD
Triazolam—Deafness—Memantine—Alzheimer's disease	0.00223	0.00609	CcSEcCtD
Triazolam—Hepatic failure—Memantine—Alzheimer's disease	0.00222	0.00606	CcSEcCtD
Triazolam—GABRG3—nervous system—Alzheimer's disease	0.00221	0.013	CbGeAlD
Triazolam—Osteoarthritis—Donepezil—Alzheimer's disease	0.0022	0.006	CcSEcCtD
Triazolam—GABRR2—nervous system—Alzheimer's disease	0.00219	0.0129	CbGeAlD
Triazolam—GABRG2—telencephalon—Alzheimer's disease	0.00218	0.0129	CbGeAlD
Triazolam—GABRB2—telencephalon—Alzheimer's disease	0.00218	0.0129	CbGeAlD
Triazolam—Deafness—Rivastigmine—Alzheimer's disease	0.00218	0.00595	CcSEcCtD
Triazolam—GABRA2—forebrain—Alzheimer's disease	0.00217	0.0128	CbGeAlD
Triazolam—Affect lability—Donepezil—Alzheimer's disease	0.00216	0.0059	CcSEcCtD
Triazolam—GABRG3—central nervous system—Alzheimer's disease	0.00213	0.0125	CbGeAlD
Triazolam—Amnesia—Memantine—Alzheimer's disease	0.00212	0.0058	CcSEcCtD
Triazolam—GABRR1—nervous system—Alzheimer's disease	0.00211	0.0124	CbGeAlD
Triazolam—GABRA1—forebrain—Alzheimer's disease	0.0021	0.0124	CbGeAlD
Triazolam—Irritability—Donepezil—Alzheimer's disease	0.0021	0.00572	CcSEcCtD
Triazolam—Urinary retention—Donepezil—Alzheimer's disease	0.00209	0.0057	CcSEcCtD
Triazolam—Mood swings—Donepezil—Alzheimer's disease	0.00208	0.00568	CcSEcCtD
Triazolam—Amnesia—Rivastigmine—Alzheimer's disease	0.00208	0.00567	CcSEcCtD
Triazolam—Ataxia—Donepezil—Alzheimer's disease	0.00207	0.00564	CcSEcCtD
Triazolam—GABRR2—cerebellum—Alzheimer's disease	0.00206	0.0121	CbGeAlD
Triazolam—GABRR1—central nervous system—Alzheimer's disease	0.00203	0.0119	CbGeAlD
Triazolam—TSPO—forebrain—Alzheimer's disease	0.00201	0.0118	CbGeAlD
Triazolam—GABRA2—telencephalon—Alzheimer's disease	0.002	0.0118	CbGeAlD
Triazolam—Osteoarthritis—Memantine—Alzheimer's disease	0.00199	0.00544	CcSEcCtD
Triazolam—Cramp muscle—Donepezil—Alzheimer's disease	0.00198	0.0054	CcSEcCtD
Triazolam—Affect lability—Memantine—Alzheimer's disease	0.00196	0.00536	CcSEcCtD
Triazolam—Osteoarthritis—Rivastigmine—Alzheimer's disease	0.00195	0.00533	CcSEcCtD
Triazolam—Hallucination—Galantamine—Alzheimer's disease	0.00195	0.00533	CcSEcCtD
Triazolam—Muscular weakness—Donepezil—Alzheimer's disease	0.00194	0.00529	CcSEcCtD
Triazolam—GABRQ—brain—Alzheimer's disease	0.00193	0.0114	CbGeAlD
Triazolam—GABRA1—telencephalon—Alzheimer's disease	0.00193	0.0114	CbGeAlD
Triazolam—Affect lability—Rivastigmine—Alzheimer's disease	0.00192	0.00524	CcSEcCtD
Triazolam—Irritability—Memantine—Alzheimer's disease	0.0019	0.0052	CcSEcCtD
Triazolam—Urinary retention—Memantine—Alzheimer's disease	0.0019	0.00518	CcSEcCtD
Triazolam—Visual impairment—Galantamine—Alzheimer's disease	0.00189	0.00516	CcSEcCtD
Triazolam—Mood swings—Memantine—Alzheimer's disease	0.00189	0.00516	CcSEcCtD
Triazolam—Ataxia—Memantine—Alzheimer's disease	0.00187	0.00512	CcSEcCtD
Triazolam—Urinary retention—Rivastigmine—Alzheimer's disease	0.00185	0.00506	CcSEcCtD
Triazolam—Sweating increased—Donepezil—Alzheimer's disease	0.00185	0.00505	CcSEcCtD
Triazolam—Mood swings—Rivastigmine—Alzheimer's disease	0.00185	0.00505	CcSEcCtD
Triazolam—TSPO—telencephalon—Alzheimer's disease	0.00185	0.0109	CbGeAlD
Triazolam—Ataxia—Rivastigmine—Alzheimer's disease	0.00183	0.00501	CcSEcCtD
Triazolam—GABRD—nervous system—Alzheimer's disease	0.00183	0.0108	CbGeAlD
Triazolam—Tinnitus—Galantamine—Alzheimer's disease	0.00183	0.00499	CcSEcCtD
Triazolam—GABRB3—forebrain—Alzheimer's disease	0.00182	0.0107	CbGeAlD
Triazolam—Dysuria—Donepezil—Alzheimer's disease	0.00177	0.00485	CcSEcCtD
Triazolam—GABRD—central nervous system—Alzheimer's disease	0.00176	0.0104	CbGeAlD
Triazolam—GABRG1—nervous system—Alzheimer's disease	0.00176	0.0104	CbGeAlD
Triazolam—Muscular weakness—Memantine—Alzheimer's disease	0.00176	0.0048	CcSEcCtD
Triazolam—Cramp muscle—Rivastigmine—Alzheimer's disease	0.00176	0.0048	CcSEcCtD
Triazolam—GABRA6—nervous system—Alzheimer's disease	0.00175	0.0103	CbGeAlD
Triazolam—GABRD—cerebellum—Alzheimer's disease	0.00172	0.0101	CbGeAlD
Triazolam—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00172	0.0047	CcSEcCtD
Triazolam—GABRB1—nervous system—Alzheimer's disease	0.00171	0.0101	CbGeAlD
Triazolam—GABRA5—nervous system—Alzheimer's disease	0.0017	0.01	CbGeAlD
Triazolam—GABRG1—central nervous system—Alzheimer's disease	0.0017	0.00999	CbGeAlD
Triazolam—GABRG3—brain—Alzheimer's disease	0.00169	0.00995	CbGeAlD
Triazolam—GABRA6—central nervous system—Alzheimer's disease	0.00169	0.00993	CbGeAlD
Triazolam—Flatulence—Galantamine—Alzheimer's disease	0.00168	0.00459	CcSEcCtD
Triazolam—Sweating increased—Memantine—Alzheimer's disease	0.00168	0.00458	CcSEcCtD
Triazolam—GABRB3—telencephalon—Alzheimer's disease	0.00168	0.00988	CbGeAlD
Triazolam—Tension—Galantamine—Alzheimer's disease	0.00167	0.00457	CcSEcCtD
Triazolam—Dysgeusia—Galantamine—Alzheimer's disease	0.00167	0.00456	CcSEcCtD
Triazolam—GABRG1—cerebellum—Alzheimer's disease	0.00166	0.00976	CbGeAlD
Triazolam—Nervousness—Galantamine—Alzheimer's disease	0.00166	0.00453	CcSEcCtD
Triazolam—Jaundice—Donepezil—Alzheimer's disease	0.00165	0.0045	CcSEcCtD
Triazolam—GABRA6—cerebellum—Alzheimer's disease	0.00165	0.00971	CbGeAlD
Triazolam—GABRB1—central nervous system—Alzheimer's disease	0.00164	0.00969	CbGeAlD
Triazolam—Sweating increased—Rivastigmine—Alzheimer's disease	0.00164	0.00448	CcSEcCtD
Triazolam—Muscle spasms—Galantamine—Alzheimer's disease	0.00164	0.00448	CcSEcCtD
Triazolam—GABRA5—central nervous system—Alzheimer's disease	0.00164	0.00963	CbGeAlD
Triazolam—Dysuria—Memantine—Alzheimer's disease	0.00161	0.0044	CcSEcCtD
Triazolam—GABRR1—brain—Alzheimer's disease	0.00161	0.00948	CbGeAlD
Triazolam—GABRB1—cerebellum—Alzheimer's disease	0.00161	0.00947	CbGeAlD
Triazolam—Tremor—Galantamine—Alzheimer's disease	0.0016	0.00437	CcSEcCtD
Triazolam—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00158	0.00432	CcSEcCtD
Triazolam—GABRA3—nervous system—Alzheimer's disease	0.00158	0.00931	CbGeAlD
Triazolam—Dysuria—Rivastigmine—Alzheimer's disease	0.00158	0.0043	CcSEcCtD
Triazolam—Agitation—Galantamine—Alzheimer's disease	0.00157	0.00428	CcSEcCtD
Triazolam—GABRA4—nervous system—Alzheimer's disease	0.00154	0.00908	CbGeAlD
Triazolam—Malaise—Galantamine—Alzheimer's disease	0.00154	0.0042	CcSEcCtD
Triazolam—Syncope—Galantamine—Alzheimer's disease	0.00153	0.00418	CcSEcCtD
Triazolam—GABRA3—central nervous system—Alzheimer's disease	0.00152	0.00897	CbGeAlD
Triazolam—Hallucination—Donepezil—Alzheimer's disease	0.00151	0.00413	CcSEcCtD
Triazolam—Palpitations—Galantamine—Alzheimer's disease	0.00151	0.00412	CcSEcCtD
Triazolam—Drowsiness—Rivastigmine—Alzheimer's disease	0.0015	0.0041	CcSEcCtD
Triazolam—Loss of consciousness—Galantamine—Alzheimer's disease	0.0015	0.0041	CcSEcCtD
Triazolam—GABRA4—central nervous system—Alzheimer's disease	0.00148	0.00874	CbGeAlD
Triazolam—Hypertension—Galantamine—Alzheimer's disease	0.00147	0.00402	CcSEcCtD
Triazolam—Visual impairment—Donepezil—Alzheimer's disease	0.00146	0.004	CcSEcCtD
Triazolam—Chest pain—Galantamine—Alzheimer's disease	0.00145	0.00397	CcSEcCtD
Triazolam—GABRA4—cerebellum—Alzheimer's disease	0.00145	0.00854	CbGeAlD
Triazolam—Anxiety—Galantamine—Alzheimer's disease	0.00145	0.00395	CcSEcCtD
Triazolam—Discomfort—Galantamine—Alzheimer's disease	0.00144	0.00392	CcSEcCtD
Triazolam—Dry mouth—Galantamine—Alzheimer's disease	0.00142	0.00388	CcSEcCtD
Triazolam—Tinnitus—Donepezil—Alzheimer's disease	0.00142	0.00387	CcSEcCtD
Triazolam—Confusional state—Galantamine—Alzheimer's disease	0.0014	0.00383	CcSEcCtD
Triazolam—GABRD—brain—Alzheimer's disease	0.0014	0.00824	CbGeAlD
Triazolam—Hallucination—Memantine—Alzheimer's disease	0.00137	0.00375	CcSEcCtD
Triazolam—Shock—Galantamine—Alzheimer's disease	0.00137	0.00374	CcSEcCtD
Triazolam—Tachycardia—Galantamine—Alzheimer's disease	0.00136	0.00371	CcSEcCtD
Triazolam—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00135	0.00368	CcSEcCtD
Triazolam—GABRG1—brain—Alzheimer's disease	0.00135	0.00793	CbGeAlD
Triazolam—Hallucination—Rivastigmine—Alzheimer's disease	0.00134	0.00367	CcSEcCtD
Triazolam—GABRA6—brain—Alzheimer's disease	0.00134	0.00788	CbGeAlD
Triazolam—Visual impairment—Memantine—Alzheimer's disease	0.00133	0.00363	CcSEcCtD
Triazolam—Anorexia—Galantamine—Alzheimer's disease	0.00133	0.00363	CcSEcCtD
Triazolam—Erythema—Donepezil—Alzheimer's disease	0.00132	0.00361	CcSEcCtD
Triazolam—GABRB1—brain—Alzheimer's disease	0.00131	0.00769	CbGeAlD
Triazolam—Flatulence—Donepezil—Alzheimer's disease	0.0013	0.00356	CcSEcCtD
Triazolam—Visual impairment—Rivastigmine—Alzheimer's disease	0.0013	0.00355	CcSEcCtD
Triazolam—GABRA5—brain—Alzheimer's disease	0.0013	0.00765	CbGeAlD
Triazolam—Tension—Donepezil—Alzheimer's disease	0.0013	0.00354	CcSEcCtD
Triazolam—Dysgeusia—Donepezil—Alzheimer's disease	0.0013	0.00354	CcSEcCtD
Triazolam—GABRG2—nervous system—Alzheimer's disease	0.00129	0.00759	CbGeAlD
Triazolam—GABRB2—nervous system—Alzheimer's disease	0.00129	0.00759	CbGeAlD
Triazolam—Tinnitus—Memantine—Alzheimer's disease	0.00129	0.00351	CcSEcCtD
Triazolam—Nervousness—Donepezil—Alzheimer's disease	0.00128	0.00351	CcSEcCtD
Triazolam—Muscle spasms—Donepezil—Alzheimer's disease	0.00127	0.00347	CcSEcCtD
Triazolam—Insomnia—Galantamine—Alzheimer's disease	0.00126	0.00344	CcSEcCtD
Triazolam—Tinnitus—Rivastigmine—Alzheimer's disease	0.00126	0.00344	CcSEcCtD
Triazolam—Paraesthesia—Galantamine—Alzheimer's disease	0.00125	0.00341	CcSEcCtD
Triazolam—GABRB2—central nervous system—Alzheimer's disease	0.00124	0.00731	CbGeAlD
Triazolam—GABRG2—central nervous system—Alzheimer's disease	0.00124	0.00731	CbGeAlD
Triazolam—Tremor—Donepezil—Alzheimer's disease	0.00124	0.00338	CcSEcCtD
Triazolam—Somnolence—Galantamine—Alzheimer's disease	0.00124	0.00338	CcSEcCtD
Triazolam—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00123	0.00335	CcSEcCtD
Triazolam—Agitation—Donepezil—Alzheimer's disease	0.00122	0.00332	CcSEcCtD
Triazolam—GABRB2—cerebellum—Alzheimer's disease	0.00121	0.00715	CbGeAlD
Triazolam—GABRG2—cerebellum—Alzheimer's disease	0.00121	0.00715	CbGeAlD
Triazolam—Decreased appetite—Galantamine—Alzheimer's disease	0.00121	0.00331	CcSEcCtD
Triazolam—GABRA3—brain—Alzheimer's disease	0.00121	0.00712	CbGeAlD
Triazolam—Fatigue—Galantamine—Alzheimer's disease	0.0012	0.00328	CcSEcCtD
Triazolam—Malaise—Donepezil—Alzheimer's disease	0.00119	0.00326	CcSEcCtD
Triazolam—Constipation—Galantamine—Alzheimer's disease	0.00119	0.00325	CcSEcCtD
Triazolam—Syncope—Donepezil—Alzheimer's disease	0.00119	0.00324	CcSEcCtD
Triazolam—Flatulence—Memantine—Alzheimer's disease	0.00118	0.00323	CcSEcCtD
Triazolam—Tension—Memantine—Alzheimer's disease	0.00118	0.00322	CcSEcCtD
Triazolam—GABRA4—brain—Alzheimer's disease	0.00118	0.00694	CbGeAlD
Triazolam—GABRA2—nervous system—Alzheimer's disease	0.00118	0.00694	CbGeAlD
Triazolam—Dysgeusia—Memantine—Alzheimer's disease	0.00118	0.00321	CcSEcCtD
Triazolam—Erythema—Rivastigmine—Alzheimer's disease	0.00117	0.00321	CcSEcCtD
Triazolam—GABRE—nervous system—Alzheimer's disease	0.00117	0.00688	CbGeAlD
Triazolam—Nervousness—Memantine—Alzheimer's disease	0.00117	0.00318	CcSEcCtD
Triazolam—Loss of consciousness—Donepezil—Alzheimer's disease	0.00116	0.00317	CcSEcCtD
Triazolam—Flatulence—Rivastigmine—Alzheimer's disease	0.00116	0.00316	CcSEcCtD
Triazolam—Tension—Rivastigmine—Alzheimer's disease	0.00115	0.00315	CcSEcCtD
Triazolam—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00115	0.00314	CcSEcCtD
Triazolam—Feeling abnormal—Galantamine—Alzheimer's disease	0.00115	0.00313	CcSEcCtD
Triazolam—Hypertension—Donepezil—Alzheimer's disease	0.00114	0.00312	CcSEcCtD
Triazolam—Nervousness—Rivastigmine—Alzheimer's disease	0.00114	0.00312	CcSEcCtD
Triazolam—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00114	0.00311	CcSEcCtD
Triazolam—GABRA1—nervous system—Alzheimer's disease	0.00114	0.0067	CbGeAlD
Triazolam—GABRA2—central nervous system—Alzheimer's disease	0.00113	0.00668	CbGeAlD
Triazolam—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00113	0.00308	CcSEcCtD
Triazolam—Chest pain—Donepezil—Alzheimer's disease	0.00113	0.00307	CcSEcCtD
Triazolam—Tremor—Memantine—Alzheimer's disease	0.00113	0.00307	CcSEcCtD
Triazolam—GABRE—central nervous system—Alzheimer's disease	0.00112	0.00662	CbGeAlD
Triazolam—Anxiety—Donepezil—Alzheimer's disease	0.00112	0.00306	CcSEcCtD
Triazolam—Ill-defined disorder—Memantine—Alzheimer's disease	0.00111	0.00304	CcSEcCtD
Triazolam—Discomfort—Donepezil—Alzheimer's disease	0.00111	0.00304	CcSEcCtD
Triazolam—GABRA2—cerebellum—Alzheimer's disease	0.00111	0.00653	CbGeAlD
Triazolam—Agitation—Memantine—Alzheimer's disease	0.0011	0.00301	CcSEcCtD
Triazolam—Dry mouth—Donepezil—Alzheimer's disease	0.0011	0.00301	CcSEcCtD
Triazolam—Abdominal pain—Galantamine—Alzheimer's disease	0.0011	0.00301	CcSEcCtD
Triazolam—Tremor—Rivastigmine—Alzheimer's disease	0.0011	0.00301	CcSEcCtD
Triazolam—GABRA1—central nervous system—Alzheimer's disease	0.0011	0.00646	CbGeAlD
Triazolam—TSPO—nervous system—Alzheimer's disease	0.00109	0.00642	CbGeAlD
Triazolam—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00109	0.00298	CcSEcCtD
Triazolam—Confusional state—Donepezil—Alzheimer's disease	0.00109	0.00297	CcSEcCtD
Triazolam—Malaise—Memantine—Alzheimer's disease	0.00108	0.00296	CcSEcCtD
Triazolam—Agitation—Rivastigmine—Alzheimer's disease	0.00108	0.00295	CcSEcCtD
Triazolam—Oedema—Donepezil—Alzheimer's disease	0.00108	0.00295	CcSEcCtD
Triazolam—Syncope—Memantine—Alzheimer's disease	0.00108	0.00294	CcSEcCtD
Triazolam—GABRA1—cerebellum—Alzheimer's disease	0.00107	0.00631	CbGeAlD
Triazolam—Shock—Donepezil—Alzheimer's disease	0.00106	0.0029	CcSEcCtD
Triazolam—Palpitations—Memantine—Alzheimer's disease	0.00106	0.0029	CcSEcCtD
Triazolam—Malaise—Rivastigmine—Alzheimer's disease	0.00106	0.00289	CcSEcCtD
Triazolam—Loss of consciousness—Memantine—Alzheimer's disease	0.00106	0.00288	CcSEcCtD
Triazolam—Syncope—Rivastigmine—Alzheimer's disease	0.00105	0.00288	CcSEcCtD
Triazolam—TSPO—central nervous system—Alzheimer's disease	0.00105	0.00618	CbGeAlD
Triazolam—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00104	0.00285	CcSEcCtD
Triazolam—Palpitations—Rivastigmine—Alzheimer's disease	0.00104	0.00283	CcSEcCtD
Triazolam—Hypertension—Memantine—Alzheimer's disease	0.00104	0.00283	CcSEcCtD
Triazolam—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00103	0.00282	CcSEcCtD
Triazolam—Anorexia—Donepezil—Alzheimer's disease	0.00103	0.00281	CcSEcCtD
Triazolam—Hypersensitivity—Galantamine—Alzheimer's disease	0.00103	0.0028	CcSEcCtD
Triazolam—TSPO—cerebellum—Alzheimer's disease	0.00103	0.00604	CbGeAlD
Triazolam—Chest pain—Memantine—Alzheimer's disease	0.00102	0.00279	CcSEcCtD
Triazolam—Anxiety—Memantine—Alzheimer's disease	0.00102	0.00278	CcSEcCtD
Triazolam—Hypertension—Rivastigmine—Alzheimer's disease	0.00101	0.00277	CcSEcCtD
Triazolam—Discomfort—Memantine—Alzheimer's disease	0.00101	0.00276	CcSEcCtD
Triazolam—Chest pain—Rivastigmine—Alzheimer's disease	0.001	0.00273	CcSEcCtD
Triazolam—Dry mouth—Memantine—Alzheimer's disease	0.001	0.00273	CcSEcCtD
Triazolam—Asthenia—Galantamine—Alzheimer's disease	0.000999	0.00273	CcSEcCtD
Triazolam—Anxiety—Rivastigmine—Alzheimer's disease	0.000997	0.00272	CcSEcCtD
Triazolam—GABRB3—nervous system—Alzheimer's disease	0.00099	0.00583	CbGeAlD
Triazolam—Confusional state—Memantine—Alzheimer's disease	0.000988	0.0027	CcSEcCtD
Triazolam—Discomfort—Rivastigmine—Alzheimer's disease	0.000988	0.0027	CcSEcCtD
Triazolam—GABRB2—brain—Alzheimer's disease	0.000985	0.0058	CbGeAlD
Triazolam—GABRG2—brain—Alzheimer's disease	0.000985	0.0058	CbGeAlD
Triazolam—Oedema—Memantine—Alzheimer's disease	0.00098	0.00268	CcSEcCtD
Triazolam—Dry mouth—Rivastigmine—Alzheimer's disease	0.000978	0.00267	CcSEcCtD
Triazolam—Insomnia—Donepezil—Alzheimer's disease	0.000976	0.00267	CcSEcCtD
Triazolam—Paraesthesia—Donepezil—Alzheimer's disease	0.000969	0.00265	CcSEcCtD
Triazolam—Confusional state—Rivastigmine—Alzheimer's disease	0.000967	0.00264	CcSEcCtD
Triazolam—Shock—Memantine—Alzheimer's disease	0.000964	0.00263	CcSEcCtD
Triazolam—Dyspnoea—Donepezil—Alzheimer's disease	0.000962	0.00263	CcSEcCtD
Triazolam—Somnolence—Donepezil—Alzheimer's disease	0.00096	0.00262	CcSEcCtD
Triazolam—Oedema—Rivastigmine—Alzheimer's disease	0.000959	0.00262	CcSEcCtD
Triazolam—Tachycardia—Memantine—Alzheimer's disease	0.000957	0.00261	CcSEcCtD
Triazolam—GABRB3—central nervous system—Alzheimer's disease	0.000953	0.00561	CbGeAlD
Triazolam—Diarrhoea—Galantamine—Alzheimer's disease	0.000953	0.0026	CcSEcCtD
Triazolam—Hyperhidrosis—Memantine—Alzheimer's disease	0.000947	0.00259	CcSEcCtD
Triazolam—Shock—Rivastigmine—Alzheimer's disease	0.000943	0.00258	CcSEcCtD
Triazolam—Decreased appetite—Donepezil—Alzheimer's disease	0.000938	0.00256	CcSEcCtD
Triazolam—Tachycardia—Rivastigmine—Alzheimer's disease	0.000936	0.00256	CcSEcCtD
Triazolam—Anorexia—Memantine—Alzheimer's disease	0.000934	0.00255	CcSEcCtD
Triazolam—GABRB3—cerebellum—Alzheimer's disease	0.000932	0.00549	CbGeAlD
Triazolam—Fatigue—Donepezil—Alzheimer's disease	0.000931	0.00254	CcSEcCtD
Triazolam—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000927	0.00253	CcSEcCtD
Triazolam—Constipation—Donepezil—Alzheimer's disease	0.000923	0.00252	CcSEcCtD
Triazolam—Pain—Donepezil—Alzheimer's disease	0.000923	0.00252	CcSEcCtD
Triazolam—Dizziness—Galantamine—Alzheimer's disease	0.000921	0.00251	CcSEcCtD
Triazolam—Anorexia—Rivastigmine—Alzheimer's disease	0.000914	0.0025	CcSEcCtD
Triazolam—GABRA2—brain—Alzheimer's disease	0.0009	0.0053	CbGeAlD
Triazolam—GABRE—brain—Alzheimer's disease	0.000893	0.00526	CbGeAlD
Triazolam—Feeling abnormal—Donepezil—Alzheimer's disease	0.000889	0.00243	CcSEcCtD
Triazolam—Insomnia—Memantine—Alzheimer's disease	0.000886	0.00242	CcSEcCtD
Triazolam—Vomiting—Galantamine—Alzheimer's disease	0.000886	0.00242	CcSEcCtD
Triazolam—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000883	0.00241	CcSEcCtD
Triazolam—Paraesthesia—Memantine—Alzheimer's disease	0.00088	0.0024	CcSEcCtD
Triazolam—Dermatitis—Galantamine—Alzheimer's disease	0.000877	0.0024	CcSEcCtD
Triazolam—Dyspnoea—Memantine—Alzheimer's disease	0.000874	0.00239	CcSEcCtD
Triazolam—Headache—Galantamine—Alzheimer's disease	0.000873	0.00238	CcSEcCtD
Triazolam—Somnolence—Memantine—Alzheimer's disease	0.000871	0.00238	CcSEcCtD
Triazolam—GABRA1—brain—Alzheimer's disease	0.00087	0.00512	CbGeAlD
Triazolam—Insomnia—Rivastigmine—Alzheimer's disease	0.000867	0.00237	CcSEcCtD
Triazolam—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000861	0.00235	CcSEcCtD
Triazolam—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000855	0.00233	CcSEcCtD
Triazolam—Abdominal pain—Donepezil—Alzheimer's disease	0.000853	0.00233	CcSEcCtD
Triazolam—Somnolence—Rivastigmine—Alzheimer's disease	0.000852	0.00233	CcSEcCtD
Triazolam—Decreased appetite—Memantine—Alzheimer's disease	0.000852	0.00233	CcSEcCtD
Triazolam—Fatigue—Memantine—Alzheimer's disease	0.000845	0.00231	CcSEcCtD
Triazolam—Constipation—Memantine—Alzheimer's disease	0.000838	0.00229	CcSEcCtD
Triazolam—Pain—Memantine—Alzheimer's disease	0.000838	0.00229	CcSEcCtD
Triazolam—TSPO—brain—Alzheimer's disease	0.000833	0.00491	CbGeAlD
Triazolam—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000833	0.00228	CcSEcCtD
Triazolam—Nausea—Galantamine—Alzheimer's disease	0.000827	0.00226	CcSEcCtD
Triazolam—Fatigue—Rivastigmine—Alzheimer's disease	0.000827	0.00226	CcSEcCtD
Triazolam—Constipation—Rivastigmine—Alzheimer's disease	0.00082	0.00224	CcSEcCtD
Triazolam—Pain—Rivastigmine—Alzheimer's disease	0.00082	0.00224	CcSEcCtD
Triazolam—Feeling abnormal—Memantine—Alzheimer's disease	0.000808	0.00221	CcSEcCtD
Triazolam—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000801	0.00219	CcSEcCtD
Triazolam—Hypersensitivity—Donepezil—Alzheimer's disease	0.000795	0.00217	CcSEcCtD
Triazolam—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00079	0.00216	CcSEcCtD
Triazolam—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000784	0.00214	CcSEcCtD
Triazolam—Abdominal pain—Memantine—Alzheimer's disease	0.000775	0.00212	CcSEcCtD
Triazolam—Asthenia—Donepezil—Alzheimer's disease	0.000774	0.00211	CcSEcCtD
Triazolam—Pruritus—Donepezil—Alzheimer's disease	0.000764	0.00209	CcSEcCtD
Triazolam—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000758	0.00207	CcSEcCtD
Triazolam—GABRB3—brain—Alzheimer's disease	0.000757	0.00446	CbGeAlD
Triazolam—Diarrhoea—Donepezil—Alzheimer's disease	0.000739	0.00202	CcSEcCtD
Triazolam—Hypersensitivity—Memantine—Alzheimer's disease	0.000722	0.00197	CcSEcCtD
Triazolam—Dizziness—Donepezil—Alzheimer's disease	0.000714	0.00195	CcSEcCtD
Triazolam—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000706	0.00193	CcSEcCtD
Triazolam—Asthenia—Memantine—Alzheimer's disease	0.000703	0.00192	CcSEcCtD
Triazolam—Pruritus—Memantine—Alzheimer's disease	0.000693	0.00189	CcSEcCtD
Triazolam—Asthenia—Rivastigmine—Alzheimer's disease	0.000688	0.00188	CcSEcCtD
Triazolam—Vomiting—Donepezil—Alzheimer's disease	0.000686	0.00187	CcSEcCtD
Triazolam—Dermatitis—Donepezil—Alzheimer's disease	0.00068	0.00186	CcSEcCtD
Triazolam—Pruritus—Rivastigmine—Alzheimer's disease	0.000678	0.00185	CcSEcCtD
Triazolam—Headache—Donepezil—Alzheimer's disease	0.000676	0.00185	CcSEcCtD
Triazolam—Diarrhoea—Memantine—Alzheimer's disease	0.000671	0.00183	CcSEcCtD
Triazolam—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000656	0.00179	CcSEcCtD
Triazolam—Dizziness—Memantine—Alzheimer's disease	0.000648	0.00177	CcSEcCtD
Triazolam—Nausea—Donepezil—Alzheimer's disease	0.000641	0.00175	CcSEcCtD
Triazolam—Dizziness—Rivastigmine—Alzheimer's disease	0.000634	0.00173	CcSEcCtD
Triazolam—Vomiting—Memantine—Alzheimer's disease	0.000623	0.0017	CcSEcCtD
Triazolam—Dermatitis—Memantine—Alzheimer's disease	0.000617	0.00169	CcSEcCtD
Triazolam—Headache—Memantine—Alzheimer's disease	0.000614	0.00168	CcSEcCtD
Triazolam—Vomiting—Rivastigmine—Alzheimer's disease	0.00061	0.00166	CcSEcCtD
Triazolam—Dermatitis—Rivastigmine—Alzheimer's disease	0.000604	0.00165	CcSEcCtD
Triazolam—Headache—Rivastigmine—Alzheimer's disease	0.000601	0.00164	CcSEcCtD
Triazolam—Nausea—Memantine—Alzheimer's disease	0.000582	0.00159	CcSEcCtD
Triazolam—CYP2C8—brain—Alzheimer's disease	0.000572	0.00337	CbGeAlD
Triazolam—Nausea—Rivastigmine—Alzheimer's disease	0.000569	0.00155	CcSEcCtD
Triazolam—CYP3A4—nervous system—Alzheimer's disease	0.000507	0.00299	CbGeAlD
Triazolam—CYP3A4—central nervous system—Alzheimer's disease	0.000488	0.00287	CbGeAlD
Triazolam—Chlorprothixene—HTR6—Alzheimer's disease	0.00036	0.502	CrCbGaD
Triazolam—Chlordiazepoxide—CYP2D6—Alzheimer's disease	0.000145	0.203	CrCbGaD
Triazolam—Chlorprothixene—HTR2A—Alzheimer's disease	0.000106	0.148	CrCbGaD
Triazolam—Diazepam—PTGS1—Alzheimer's disease	0.000105	0.147	CrCbGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	8.22e-05	0.000389	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—CREB1—Alzheimer's disease	8.19e-05	0.000387	CbGpPWpGaD
Triazolam—CYP2C9—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	8.15e-05	0.000385	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	8.12e-05	0.000384	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	8.12e-05	0.000384	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—CASP3—Alzheimer's disease	8.07e-05	0.000381	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—CREB1—Alzheimer's disease	8.06e-05	0.000381	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—CALM1—Alzheimer's disease	8.05e-05	0.000381	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—TF—Alzheimer's disease	8.04e-05	0.00038	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—PTGS1—Alzheimer's disease	7.91e-05	0.000374	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—CALM1—Alzheimer's disease	7.82e-05	0.00037	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—TF—Alzheimer's disease	7.81e-05	0.000369	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—CYP2D6—Alzheimer's disease	7.76e-05	0.000367	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—CALM1—Alzheimer's disease	7.68e-05	0.000363	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—TF—Alzheimer's disease	7.67e-05	0.000363	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	7.65e-05	0.000362	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—CREB1—Alzheimer's disease	7.63e-05	0.000361	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—CP—Alzheimer's disease	7.56e-05	0.000358	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—CALM1—Alzheimer's disease	7.55e-05	0.000357	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—TF—Alzheimer's disease	7.54e-05	0.000357	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—CREB1—Alzheimer's disease	7.53e-05	0.000356	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—CALM1—Alzheimer's disease	7.5e-05	0.000354	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—TF—Alzheimer's disease	7.49e-05	0.000354	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CA4—Alzheimer's disease	7.48e-05	0.000354	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—PRKCG—Alzheimer's disease	7.44e-05	0.000352	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—MAPK8—Alzheimer's disease	7.41e-05	0.00035	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—CALM1—Alzheimer's disease	7.36e-05	0.000348	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—TF—Alzheimer's disease	7.36e-05	0.000348	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	7.28e-05	0.000344	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	7.19e-05	0.00034	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GAPDHS—Alzheimer's disease	7.03e-05	0.000333	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—CREB1—Alzheimer's disease	6.89e-05	0.000326	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	6.88e-05	0.000325	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	6.72e-05	0.000318	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—CREB1—Alzheimer's disease	6.69e-05	0.000317	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	6.68e-05	0.000316	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ATP5A1—Alzheimer's disease	6.67e-05	0.000315	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	6.58e-05	0.000311	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—CREB1—Alzheimer's disease	6.57e-05	0.000311	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	6.51e-05	0.000308	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	6.49e-05	0.000307	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—CREB1—Alzheimer's disease	6.46e-05	0.000305	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—CALM1—Alzheimer's disease	6.43e-05	0.000304	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—TF—Alzheimer's disease	6.43e-05	0.000304	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—CREB1—Alzheimer's disease	6.42e-05	0.000303	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PLD3—Alzheimer's disease	6.36e-05	0.000301	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—DHCR24—Alzheimer's disease	6.36e-05	0.000301	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—CREB1—Alzheimer's disease	6.3e-05	0.000298	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	6.23e-05	0.000295	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	6.15e-05	0.000291	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—HSD17B10—Alzheimer's disease	6.1e-05	0.000288	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP46A1—Alzheimer's disease	5.87e-05	0.000278	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ND1—Alzheimer's disease	5.67e-05	0.000268	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	5.63e-05	0.000266	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	5.51e-05	0.000261	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—DHCR24—Alzheimer's disease	5.51e-05	0.00026	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—CREB1—Alzheimer's disease	5.51e-05	0.00026	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	5.46e-05	0.000258	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CA4—Alzheimer's disease	5.41e-05	0.000256	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	5.37e-05	0.000254	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	5.27e-05	0.000249	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	5.24e-05	0.000248	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	5.22e-05	0.000247	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	5.14e-05	0.000243	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	5.14e-05	0.000243	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	5.12e-05	0.000242	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GAPDHS—Alzheimer's disease	5.08e-05	0.00024	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	5.05e-05	0.000239	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ATP5A1—Alzheimer's disease	4.82e-05	0.000228	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	4.72e-05	0.000223	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CA4—Alzheimer's disease	4.68e-05	0.000221	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PLD3—Alzheimer's disease	4.6e-05	0.000217	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	4.58e-05	0.000216	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	4.5e-05	0.000213	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	4.48e-05	0.000212	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—HSD17B10—Alzheimer's disease	4.41e-05	0.000208	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GAPDHS—Alzheimer's disease	4.4e-05	0.000208	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—AKT1—Alzheimer's disease	4.37e-05	0.000206	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP46A1—Alzheimer's disease	4.24e-05	0.000201	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	4.18e-05	0.000198	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ATP5A1—Alzheimer's disease	4.18e-05	0.000197	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ND1—Alzheimer's disease	4.1e-05	0.000194	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PLD3—Alzheimer's disease	3.98e-05	0.000188	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	3.98e-05	0.000188	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	3.94e-05	0.000186	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HSD17B10—Alzheimer's disease	3.82e-05	0.000181	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CA4—Alzheimer's disease	3.81e-05	0.00018	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	3.81e-05	0.00018	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.73e-05	0.000176	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	3.73e-05	0.000176	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP46A1—Alzheimer's disease	3.68e-05	0.000174	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CHAT—Alzheimer's disease	3.65e-05	0.000173	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—TPI1—Alzheimer's disease	3.65e-05	0.000173	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	3.58e-05	0.000169	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ND1—Alzheimer's disease	3.55e-05	0.000168	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—MAOB—Alzheimer's disease	3.5e-05	0.000166	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.47e-05	0.000164	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	3.4e-05	0.000161	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GAPDH—Alzheimer's disease	3.37e-05	0.000159	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—A2M—Alzheimer's disease	3.26e-05	0.000154	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PLD3—Alzheimer's disease	3.24e-05	0.000153	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	3.24e-05	0.000153	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	3.2e-05	0.000152	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.17e-05	0.00015	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	3.11e-05	0.000147	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.04e-05	0.000144	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	2.99e-05	0.000141	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	2.96e-05	0.00014	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ND1—Alzheimer's disease	2.89e-05	0.000137	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ACHE—Alzheimer's disease	2.83e-05	0.000134	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.82e-05	0.000134	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—INPP5D—Alzheimer's disease	2.8e-05	0.000132	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.74e-05	0.000129	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ENO1—Alzheimer's disease	2.65e-05	0.000126	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTGS1—Alzheimer's disease	2.65e-05	0.000126	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CHAT—Alzheimer's disease	2.64e-05	0.000125	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—TPI1—Alzheimer's disease	2.64e-05	0.000125	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP2D6—Alzheimer's disease	2.6e-05	0.000123	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.58e-05	0.000122	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—MAOB—Alzheimer's disease	2.53e-05	0.00012	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CA4—Alzheimer's disease	2.51e-05	0.000119	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.49e-05	0.000118	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—BCHE—Alzheimer's disease	2.47e-05	0.000117	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GAPDH—Alzheimer's disease	2.44e-05	0.000115	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	2.36e-05	0.000112	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—A2M—Alzheimer's disease	2.35e-05	0.000111	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PLCB1—Alzheimer's disease	2.33e-05	0.00011	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CHAT—Alzheimer's disease	2.29e-05	0.000108	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—TPI1—Alzheimer's disease	2.29e-05	0.000108	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ABCA1—Alzheimer's disease	2.26e-05	0.000107	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	2.24e-05	0.000106	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.23e-05	0.000105	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—MAOB—Alzheimer's disease	2.19e-05	0.000104	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PLD3—Alzheimer's disease	2.14e-05	0.000101	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	2.11e-05	9.98e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.09e-05	9.87e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.07e-05	9.78e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	2.05e-05	9.69e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ACHE—Alzheimer's disease	2.05e-05	9.68e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—A2M—Alzheimer's disease	2.04e-05	9.64e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.03e-05	9.58e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—INPP5D—Alzheimer's disease	2.02e-05	9.57e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.97e-05	9.33e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PPARGC1A—Alzheimer's disease	1.95e-05	9.2e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—HMOX1—Alzheimer's disease	1.94e-05	9.16e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ENO1—Alzheimer's disease	1.92e-05	9.07e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTGS1—Alzheimer's disease	1.92e-05	9.07e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.91e-05	9.01e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP2D6—Alzheimer's disease	1.88e-05	8.9e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.86e-05	8.8e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.86e-05	8.8e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.82e-05	8.6e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MAOB—Alzheimer's disease	1.79e-05	8.44e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—BCHE—Alzheimer's disease	1.78e-05	8.44e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ACHE—Alzheimer's disease	1.77e-05	8.39e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—LPL—Alzheimer's disease	1.77e-05	8.38e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	1.75e-05	8.29e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	1.72e-05	8.12e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.7e-05	8.03e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PLCB1—Alzheimer's disease	1.68e-05	7.96e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.68e-05	7.96e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ENO1—Alzheimer's disease	1.66e-05	7.86e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	1.66e-05	7.86e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—A2M—Alzheimer's disease	1.66e-05	7.85e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	1.63e-05	7.72e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	1.63e-05	7.71e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—MTHFR—Alzheimer's disease	1.59e-05	7.54e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—BCHE—Alzheimer's disease	1.55e-05	7.31e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CALM1—Alzheimer's disease	1.49e-05	7.05e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—APOE—Alzheimer's disease	1.48e-05	7.02e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.48e-05	7e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CAV1—Alzheimer's disease	1.47e-05	6.96e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	1.46e-05	6.89e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ACHE—Alzheimer's disease	1.44e-05	6.83e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.43e-05	6.76e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	1.43e-05	6.75e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	1.41e-05	6.68e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	1.41e-05	6.65e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	1.4e-05	6.62e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ENO1—Alzheimer's disease	1.35e-05	6.4e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	1.35e-05	6.4e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	1.33e-05	6.27e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PPARG—Alzheimer's disease	1.29e-05	6.12e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—LPL—Alzheimer's disease	1.28e-05	6.05e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—INS—Alzheimer's disease	1.27e-05	6e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—BCHE—Alzheimer's disease	1.26e-05	5.95e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.23e-05	5.81e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.23e-05	5.81e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	1.22e-05	5.76e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	1.21e-05	5.73e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	1.19e-05	5.61e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.18e-05	5.57e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.16e-05	5.5e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	1.15e-05	5.45e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	1.15e-05	5.44e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.13e-05	5.36e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NOS3—Alzheimer's disease	1.11e-05	5.26e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—LPL—Alzheimer's disease	1.11e-05	5.24e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.09e-05	5.17e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CALM1—Alzheimer's disease	1.08e-05	5.09e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APOE—Alzheimer's disease	1.07e-05	5.07e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CAV1—Alzheimer's disease	1.06e-05	5.03e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	1.02e-05	4.81e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	9.99e-06	4.72e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	9.91e-06	4.69e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	9.87e-06	4.67e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ACHE—Alzheimer's disease	9.52e-06	4.5e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	9.41e-06	4.45e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PPARG—Alzheimer's disease	9.35e-06	4.42e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CALM1—Alzheimer's disease	9.33e-06	4.41e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APOE—Alzheimer's disease	9.3e-06	4.4e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CAV1—Alzheimer's disease	9.21e-06	4.36e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—INS—Alzheimer's disease	9.17e-06	4.34e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—LPL—Alzheimer's disease	9.03e-06	4.27e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ENO1—Alzheimer's disease	8.92e-06	4.22e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	8.92e-06	4.22e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	8.75e-06	4.14e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—BCHE—Alzheimer's disease	8.29e-06	3.92e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	8.13e-06	3.84e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PPARG—Alzheimer's disease	8.1e-06	3.83e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NOS3—Alzheimer's disease	8.04e-06	3.8e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—INS—Alzheimer's disease	7.94e-06	3.76e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	7.83e-06	3.7e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CALM1—Alzheimer's disease	7.59e-06	3.59e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	7.59e-06	3.59e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOE—Alzheimer's disease	7.57e-06	3.58e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CAV1—Alzheimer's disease	7.5e-06	3.54e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	7.35e-06	3.48e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NOS3—Alzheimer's disease	6.96e-06	3.29e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PPARG—Alzheimer's disease	6.59e-06	3.12e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	6.54e-06	3.09e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	6.51e-06	3.08e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—INS—Alzheimer's disease	6.46e-06	3.06e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	6.37e-06	3.01e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LPL—Alzheimer's disease	5.95e-06	2.81e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NOS3—Alzheimer's disease	5.67e-06	2.68e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	5.36e-06	2.53e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	5.18e-06	2.45e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—AKT1—Alzheimer's disease	5.11e-06	2.42e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CALM1—Alzheimer's disease	5.01e-06	2.37e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOE—Alzheimer's disease	4.99e-06	2.36e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CAV1—Alzheimer's disease	4.94e-06	2.34e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPARG—Alzheimer's disease	4.35e-06	2.06e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—INS—Alzheimer's disease	4.26e-06	2.02e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NOS3—Alzheimer's disease	3.74e-06	1.77e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—AKT1—Alzheimer's disease	3.7e-06	1.75e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	3.42e-06	1.62e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—AKT1—Alzheimer's disease	3.2e-06	1.51e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—AKT1—Alzheimer's disease	2.61e-06	1.23e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.72e-06	8.13e-06	CbGpPWpGaD
